Background: Previous studies have demonstrated the efficacy of the “drip-and-ship” model in acute ischemic stroke (AIS) patients treated with intravenous (IV) thrombolysis. We investigated and report the outcomes of the safety and efficacy of the “drip-and-ship” model in AIS patients with acute large-vessel occlusion (LVO) in the anterior circulation who underwent endovascular treatment. Methods: A total of 92 AIS patients with LVO who underwent endovascular treatment enrolled from April 2017 to July 2018 at a single academic comprehensive stroke center (CSC) were included. Patients were divided into 2 groups: a front-door group (directly admitted to the CSC) and a drip-and-ship group (transferred to the CSC from other hospital). Logistic regression model was used to evaluate the functional outcome, mortality, and symptomatic intracranial hemorrhage (sICH) at 90 days. Results: After adjusting for age, gender, occlusion site, National Institutes of Health Stroke Scale (NIHSS) score, and other potential covariates, we did not see difference in modified Rankin Scale (mRS) score between the 2 groups at 90 days. The rate of excellent functional outcome (defined as mRS 0–1) in the drip-and-ship group is lower than the front-door group (p = 0.017); however, functional outcomes (defined as mRS 0–2) have no difference (p = 0.117). There was no significant difference in sICH (p = 0.909) and mortality (p = 0.319) between the 2 groups. Conclusions: The “drip-and-ship” model has the potential to be a feasible model for patients with LVO in the anterior circulation to undergo endovascular treatment. Further large-scale prospective studies are warranted to confirm these findings.

1.
Berkhemer
OA
,
Fransen
PS
,
Beumer
D
,
Van den Berg
LA
,
Lingsma
HF
,
Yoo
AJ
, et al
A randomized trial of intraarterial treatment for acute ischemic stroke
.
N Engl J Med
.
2015
;
372
(
1
):
11
20
. .
2.
Goyal
M
,
Demchuk
AM
,
Menon
BK
,
Eesa
M
,
Rempel
JL
,
Thornton
J
, et al
Randomized assessment of rapid endovascular treatment of ischemic stroke
.
N Engl J Med
.
2015
;
372
(
11
):
1019
30
. .
3.
Campbell
BC
,
Mitchell
PJ
,
Kleinig
TJ
,
Dewey
HM
,
Churilov
L
,
Yassi
N
, et al
Endovascular therapy for ischemic stroke with perfusion-imaging selection
.
N Engl J Med
.
2015
;
372
(
11
):
1009
18
. .
4.
Jovin
TG
,
Chamorro
A
,
Cobo
E
,
de Miquel
MA
,
Molina
CA
,
Rovira
A
, et al
Thrombectomy within 8 hours after symptom onset in ischemic stroke
.
N Engl J Med
.
2015
;
372
(
24
):
2296
306
. .
5.
Saver
JL
,
Goyal
M
,
Bonafe
A
,
Diener
HC
,
Levy
EI
,
Pereira
VM
, et al
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke
.
N Engl J Med
.
2015
;
372
(
24
):
2285
95
. .
6.
Mocco
J
,
Zaidat
OO
,
von Kummer
R
,
Yoo
AJ
,
Gupta
R
,
Lopes
D
, et al
Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone
.
Stroke
.
2016
;
47
(
9
):
2331
8
. .
7.
Bracard
S
,
Ducrocq
X
,
Mas
JL
,
Soudant
M
,
Oppenheim
C
,
Moulin
T
, et al
Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomized controlled trial
.
Lancet Neurol
.
2016
;
15
:
1138
47
.
8.
Muir
KW
,
Ford
GA
,
Messow
CM
,
Ford
I
,
Murray
A
,
Clifton
A
, et al
Endovascular therapy for acute ischaemic stroke: the pragmatic ischaemic stroke thrombectomy evaluation (PISTE) randomised, controlled trial
.
J Neurol Neurosurg Psychiatry
.
2017
;
88
(
1
):
38
44
. .
9.
Saver
JL
.
Time is brain-quantified
.
Stroke
.
2006
;
37
(
1
):
263
6
. .
10.
Merino
JG
,
Silver
B
,
Wong
E
,
Foell
B
,
Demaerschalk
B
,
Tamayo
A
, et al
Extending tissue plasminogen activator use to community and rural stroke patients
.
Stroke
.
2002
;
33
(
1
):
141
6
. .
11.
Rymer
MM
,
Thurtchley
D
,
Summers
D
,
America Brain and Stroke Institute Stroke Team
.
Expanded modes of tissue plasminogen activator delivery in a comprehensive stroke center increases regional acute stroke interventions
.
Stroke
.
2003
;
34
(
6
):
e58
60
. .
12.
Asaithambi
G
,
Chaudhry
SA
,
Hassan
AE
,
Rodriguez
GJ
,
Suri
MF
,
Qureshi
AI
.
Adherence to guidelines by emergency medical services during transport of stroke patients receiving intravenous thrombolytic infusion
.
J Stroke Cerebrovasc Dis
.
2003
;
22
(
7
):
e42
5
. .
13.
Mansoor
S
,
Zand
R
,
Al-Wafai
A
,
Wahba
MN
,
Giraldo
EA
.
Safety of a “drip and ship” intravenous thrombolysis protocol for patients with acute ischemic stroke
.
J Stroke Cerebrovasc Dis
.
2013
;
22
(
7
):
969
71
. .
14.
Martin-Schild
S
,
Morales
MM
,
Khaja
AM
,
Barreto
AD
,
Hallevi
H
,
Abraham
A
, et al
Is the drip-and-ship approach to delivering thrombolysis for acute ischemic stroke safe?
J Emerg Med
.
2011
;
41
(
2
):
135
41
. .
15.
Qureshi
AI
,
Chaudhry
SA
,
Rodriguez
GJ
,
Suri
MFK
,
Lakshminarayan
K
,
Ezzeddine
MA
.
Outcome of the ‘drip-and-ship’ paradigm among patients with acute ischemic stroke: results of a statewide study
.
Cerebrovasc Dis Extra
.
2012
;
2
:
1
8
.
16.
Silverman
IE
,
Beland
DK
,
Chhabra
J
,
McCullough
LD
.
The drip and ship approach: starting IV t-PA for acute ischemic stroke at outside hospitals prior to transfer to a regional stroke center
.
Conn Med
.
2005
;
69
:
613
20
.
17.
Tekle
WG
,
Chaudhry
SA
,
Hassan
AE
,
Rodriguez
GJ
,
Suri
MF
,
Qureshi
AI
.
Drip-and-ship thrombolytic treatment paradigm among acute ischemic stroke patients in the United States
.
Stroke
.
2012
;
43
(
7
):
1971
4
. .
18.
Sheth
KN
,
Smith
EE
,
Grau-Sepulveda
MV
,
Kleindorfer
D
,
Fonarow
GC
,
Schwamm
LH
, et al
Drip and ship thrombolytic therapy for acute ischemic stroke: use, temporal trends, and outcomes
.
Stroke
.
2015
;
46
(
3
):
732
9
. .
19.
Park
MS
,
Yoon
W
,
Kim
JT
,
Choi
KH
,
Kang
SH
,
Kim
BC
, et al
Drip, ship, and on-demand endovascular therapy for acute ischemic stroke
.
PLoS One
.
2016
;
11
(
3
):
e0150668
.
20.
Froehler
MT
,
Saver
JL
,
Zaidat
OO
,
Jahan
R
,
Aziz-Sultan
MA
,
Klucznick
RP
, et al
Interhospital transfer prior to thrombectomy is associated with delayed treatment and worse outcome in the STRATIS registry
.
Circulation
.
2017
;
136
:
2311
21
. .
21.
Deng
S
,
Yang
N
,
Li
S
,
Wang
W
,
Yan
H
,
Li
H
.
Doctors’ job satisfaction and its relationships with doctor patient relationship and work-family conflict in China: a structural equation modeling
.
Inquiry
.
2018 Jan–Dec
;
55
:
46958018790831
.
22.
Sun
J
,
Liu
S
,
Liu
Q
,
Wang
Z
,
Wang
J
,
Hu
CJ
, et al
Impact of adverse media reporting on public perceptions of the doctor–patient relationship in China: an analysis with propensity score matching method
.
BMJ Open
.
2018
;
8
(
8
):
e022455
.
23.
Suzuki
Y
,
Hasegawa
Y
,
Tsumura
K
,
Ueda
T
,
Suzuki
K
,
Sugiyama
M
, et al
Prehospital triage for endovascular clot removal in acute stroke patients
.
Acute Med Surg
.
2017
;
4
(
1
):
68
74
. .
24.
Kim
J
,
Hwang
YH
,
Kim
JT
,
Choi
NC
,
Kang
SY
,
Cha
JK
, et al
Establishment of government-initiated comprehensive stroke centers for acute ischemic stroke management in South Korea
.
Stroke
.
2014
;
45
(
8
):
2391
6
. .
25.
Gerschenfeld
G
,
Muresan
IP
,
Blanc
R
,
Obadia
M
,
Abrivard
M
,
Piotin
M
, et al
Two paradigms for endovascular thrombectomy after intravenous thrombolysis for acute ischemic stroke
.
JAMA Neurol
.
2017
;
74
(
5
):
549
56
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.